ファブリー病(Fabry Disease)：世界の治験レビュー（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Fabry Disease 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Fabry Disease to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Fabry Disease to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Fabry Disease 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Fabry Disease Therapeutics Clinical Trials 30
Prominent Drugs 31
Latest Clinical Trials News on Fabry Disease 32
Apr 21, 2015: Genzyme Initiates Phase 2a Clinical Trial to Evaluate Oral Therapy for Fabry Disease 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Sanofi 33
Clinical Trial Overview of Sanofi 33
Amicus Therapeutics, Inc. 35
Clinical Trial Overview of Amicus Therapeutics, Inc. 35
Shire Plc 37
Clinical Trial Overview of Shire Plc 37
GlaxoSmithKline Plc 38
Clinical Trial Overview of GlaxoSmithKline Plc 38
Protalix BioTherapeutics, Inc. 39
Clinical Trial Overview of Protalix BioTherapeutics, Inc. 39
Green Cross Holdings Corporation 40
Clinical Trial Overview of Green Cross Holdings Corporation 40
Genzyme Corporation 41
Clinical Trial Overview of Genzyme Corporation 41
Alexion Pharmaceuticals, Inc. 42
Clinical Trial Overview of Alexion Pharmaceuticals, Inc. 42
Agility Clinical, Inc. 43
Clinical Trial Overview of Agility Clinical, Inc. 43
Abbott Laboratories 44
Clinical Trial Overview of Abbott Laboratories 44
Clinical Trial Overview of Top Institutes / Government 45
National Institute of Neurological Disorders and Stroke 45
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 45
University of Alabama at Birmingham 46
Clinical Trial Overview of University of Alabama at Birmingham 46
University of Minnesota 47
Clinical Trial Overview of University of Minnesota 47
Academic Medical Center 48
Clinical Trial Overview of Academic Medical Center 48
Assistance Publique – Hopitaux de Paris 49
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 49
Canadian Fabry Research Consortium 50
Clinical Trial Overview of Canadian Fabry Research Consortium 50
Centre Hospitalier Universitaire de Nice 51
Clinical Trial Overview of Centre Hospitalier Universitaire de Nice 51
Federico II University 52
Clinical Trial Overview of Federico II University 52
Mario Negri Institute for Pharmacological Research 53
Clinical Trial Overview of Mario Negri Institute for Pharmacological Research 53
Rigshospitalet 54
Clinical Trial Overview of Rigshospitalet 54
Five Key Clinical Profiles 55
Appendix 90
Abbreviations 90
Definitions 90
Research Methodology 91
Secondary Research 91
About GlobalData 92
Contact Us 92
Disclaimer 92
Source 92